Literature DB >> 26679230

Endoscopic vs. conventional septoplasty: A review of the literature.

C Champagne1, S Ballivet de Régloix1, L Genestier1, A Crambert1, O Maurin1, Y Pons2.   

Abstract

The aim of this review of literature was to compare conventional and endoscopic septoplasty in terms of operating time, functional efficacy and perioperative morbidity. A systematic review of the scientific literature was performed on the PubMed database, Google and Google Scholar, searching for randomized prospective trials comparing endoscopic and conventional septoplasty. The primary endpoint was operating time, and the secondary endpoints were intra- and postoperative complications, postoperative pain, hospital stay and functional result. Twenty-nine articles published between 1991 and 2012 compared conventional and endoscopic septoplasty, five of which were prospective randomized trials. Operating time was shorter with endoscopic surgery (P<0.001), with less mucosal damage (P<0.01); there was less synechia (P<0.01) and residual deformity (P<0.05); and postoperative pain was milder. Endoscopic septoplasty thus shortened surgery time and reduced perioperative complications, but the functional result was the same as with conventional septoplasty.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Endoscopic septoplasty; Literature review; Operating time

Mesh:

Year:  2015        PMID: 26679230     DOI: 10.1016/j.anorl.2015.11.004

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  2 in total

1.  Endoscopic versus conventional septoplasty: objective/subjective data on 276 patients.

Authors:  Massimiliano Garzaro; Valeria Dell'Era; Giuseppe Riva; Luca Raimondo; Giancarlo Pecorari; Paolo Aluffi Valletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-20       Impact factor: 2.503

2.  A good first step for ERAS in otolaryngoiatric field, but it is not enough.

Authors:  Massimiliano Pelli; Luigi Maggi; Monica Rocco
Journal:  Ther Clin Risk Manag       Date:  2019-01-25       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.